Study uncovers genetic drivers of aggressive prostate cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 8-May-2025 21:09 ET (9-May-2025 01:09 GMT/UTC)
The National Institutes of Health (NIH) serves as an important source of funding for clinical trials in children, especially for diseases, such as cancer, that are not as highly prioritized in industry-sponsored clinical trials, according to a recent study published in The Journal of Pediatrics. The study evaluated how the number of pediatric clinical trials, as an indicator for industry and NIH research priorities, compared with the burden of childhood disease in the United States.
DNA repair proteins act like the body’s editors, constantly finding and reversing damage to our genetic code. Researchers have long struggled to understand how cancer cells hijack one of these proteins—called polymerase theta (Pol-theta)—for their own survival. But scientists at Scripps Research have now captured the first detailed images of Pol-theta in action, revealing the molecular processes responsible for a range of cancers.
Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to fight cancer. Pyronaridine has been used to treat the mosquito-borne infectious disease for over 30 years.
The SXSW Conference will take place from March 7-15 in Austin, Texas, bringing together a vibrant mix of ideas and innovations. Once again, UC San Diego will take center stage, showcasing cutting-edge research, transformative discussions on critical global challenges and a film premiere.